Attached files
| file | filename |
|---|---|
| EX-10.23 - MB CASH CONTRIBUTION AGREEMENT - Endo International plc | ex1023mbcashcontributi.htm |
| EX-32.2 - CFO 906 CERT - Endo International plc | ex32212312019cfo906cert.htm |
| EX-32.1 - CEO 906 CERT - Endo International plc | ex32112312019ceo906cert.htm |
| EX-31.2 - CFO 302 CERT - Endo International plc | ex31212312019cfo302cert.htm |
| EX-31.1 - CEO 302 CERT - Endo International plc | ex31112312019ceo302cert.htm |
| EX-24.1 - POWER OF ATTORNEY - Endo International plc | ex24112312019powerofat.htm |
| EX-23.1 - CONSENT OF PWC - Endo International plc | ex23112312019consentof.htm |
| EX-10.24 - MB LETTER AGREEMENT - Endo International plc | ex1024mbletteragreement.htm |
| EX-10.19 - CFO AGREEMENT - Endo International plc | a1019cfoagreement.htm |
| EX-10.18.1 - CEO AGREEMENT - Endo International plc | a10181ceoagreement.htm |
| EX-4.1 - DESCRIPTION OF SECURITIES - Endo International plc | ex41descriptionofregis.htm |
| 10-K - 10-K - Endo International plc | endp-12312019x10k.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
The following is a list of significant subsidiaries of the Company as of December 31, 2019.
Subsidiary | Jurisdiction of Incorporation or Organization | Ownership by Endo International plc | ||
Actient Pharmaceuticals LLC | Delaware | Indirect | ||
Actient Therapeutics, LLC | Delaware | Indirect | ||
Anchen Pharmaceuticals 2, Inc. | Delaware | Indirect | ||
Astora Women’s Health, LLC | Delaware | Indirect | ||
Auxilium Pharmaceuticals, LLC | Delaware | Indirect | ||
Endo Designated Activity Company | Ireland | Direct | ||
Endo Eurofin Unlimited Company | Ireland | Indirect | ||
Endo Finance II Unlimited Company | Ireland | Indirect | ||
Endo Finance IV Unlimited Company | Ireland | Indirect | ||
Endo Finance Unlimited Company | Ireland | Indirect | ||
Endo Finance LLC | Delaware | Indirect | ||
Endo Finance Operations LLC | Delaware | Indirect | ||
Endo Global Biologics Limited | Ireland | Indirect | ||
Endo Health Solutions Inc. | Delaware | Indirect | ||
Endo Ireland Finance Unlimited Company | Ireland | Indirect | ||
Endo Luxembourg Finance Company I S.a r.l. | Luxembourg | Indirect | ||
Endo Luxembourg Finance Company II S.a r.l. | Luxembourg | Indirect | ||
Endo Luxembourg Holding Company S.a r.l. | Luxembourg | Indirect | ||
Endo Management Limited | Ireland | Indirect | ||
Endo Par Innovation Company, LLC | Delaware | Indirect | ||
Endo Pharmaceuticals Inc. | Delaware | Indirect | ||
Endo Pharmaceuticals Valera Inc. | Delaware | Indirect | ||
Endo TopFin Limited | Ireland | Indirect | ||
Endo U.S. Inc. | Delaware | Indirect | ||
Endo U.S. Finance LLC | Delaware | Indirect | ||
Endo US Holdings Luxembourg I S.a r.l. | Luxembourg | Indirect | ||
Endo Ventures Limited | Ireland | Indirect | ||
Generics Bidco I, LLC (doing business as Par Pharmaceutical) | Delaware | Indirect | ||
Generics International (US Parent), Inc. | Delaware | Indirect | ||
Generics International (US) 2, Inc. | Delaware | Indirect | ||
Hawk Acquisition Ireland Limited | Ireland | Indirect | ||
JHP Group Holdings 2, Inc. | Delaware | Indirect | ||
Luxembourg Endo Specialty Pharmaceuticals Holding I S.a r.l. | Luxembourg | Indirect | ||
Paladin Labs Canadian Holding Inc. | Canada | Indirect | ||
Paladin Labs Inc. | Canada | Indirect | ||
Par Pharmaceutical 2, Inc. | Delaware | Indirect | ||
Par Pharmaceutical Companies, Inc. | Delaware | Indirect | ||
Par Pharmaceutical Holdings, Inc. | Delaware | Indirect | ||
Par Pharmaceutical, Inc. (doing business as Par Pharmaceutical) | New York | Indirect | ||
Par Sterile Products, LLC | Delaware | Indirect | ||